3rd Quarter - Report
TIBER CREEK GROUP for ROIVANT SCIENCES, INC.
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues pertaining to womens health and treatment of endometriosis; treatment of rare diseases; Issues related to the development of new treatments and therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
| JEFFREY SHAPIRO | — |
Health Issues HCR
Issues pertaining to womens health and treatment of endometriosis; treatment of diabetes; treatment of rare diseases; gene therapies and treatment of Parkinsons disease
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
| JEFFREY SHAPIRO | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROIVANT SCIENCES LTD. | Bermuda | Bermuda | 100.0% | — |
| ROIVANT SCIENCES HOLDINGS LTD. | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.